Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Current Assets (2023 - 2025)

Historic Current Assets for Beta Bionics (BBNX) over the last 3 years, with Q3 2025 value amounting to $270.0 million.

  • Beta Bionics' Current Assets changed N/A to $270.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $270.0 million, marking a year-over-year change of. This contributed to the annual value of $132.9 million for FY2024, which is 2827.81% up from last year.
  • As of Q3 2025, Beta Bionics' Current Assets stood at $270.0 million.
  • Beta Bionics' 5-year Current Assets high stood at $286.1 million for Q2 2025, and its period low was $103.6 million during Q4 2023.
  • Moreover, its 3-year median value for Current Assets was $261.9 million (2025), whereas its average is $210.9 million.
  • Within the past 5 years, the most significant YoY rise in Beta Bionics' Current Assets was 2827.81% (2024), while the steepest drop was 2827.81% (2024).
  • Beta Bionics' Current Assets (Quarter) stood at $103.6 million in 2023, then increased by 28.28% to $132.9 million in 2024, then skyrocketed by 103.14% to $270.0 million in 2025.
  • Its Current Assets stands at $270.0 million for Q3 2025, versus $286.1 million for Q2 2025 and $261.9 million for Q1 2025.